logo

Springworks Therapeutics (SWTX)



Trade SWTX now with
  Date
  Headline
5/24/2022 6:48:06 AM SpringWorks Therapeutics Says Nirogacestat Meets Endpoints In Phase 3 DeFi Trial
4/19/2022 6:42:24 AM SpringWorks Therapeutics Announces Deal With Regeneron To Evaluate Nirogacestat With REGN5458
8/30/2021 6:47:29 AM SpringWorks Therapeutics In Research Partnership With Dana-Farber Institute For Nirogacestat In Multiple Myeloma
6/16/2021 6:51:09 AM SpringWorks Therapeutics Begins Phase 1/2 Clinical Trial Of Mirdametinib In Low-Grade Glioma
6/7/2021 6:37:28 AM SpringWorks Collaborate With Seagen To Evaluate Nirogacestat With SEA-BCMA In Patients With R/r Multiple Myeloma